Brinzolamde API

Brinzolamde API

Product Details:

  • Medicine Name Brinzolamde API
  • CAS No 138890-62-7
  • Type Other
  • Grade Medicine Grade
  • Usage Pharmaceutical
  • Physical Form Powder

Product Specifications

  • Powder
  • Brinzolamde API
  • Medicine Grade
  • Other
  • 138890-62-7
  • Pharmaceutical

Trade Information

  • South America, Middle East, North America, Central America, Western Europe, Eastern Europe, Asia, Australia, Africa
  • All India

Product Description

The Brinzolamide API  is a highly specific, non-competitive, reversible carbonic anhydrase inhibitor. Carbonic anhydrase (CA) is an enzyme found in many tissues of the body including the eye. Brinzolamide is a carbonic anhydrase inhibitor used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Brinzolamide was approved as a generic medication. Lowering high pressure inside the eye helps to prevent blindness. Brinzolamide API is made available by us that is very effective and safe for use.


Q: How does brinzolamide API work?

A: Brinzolamide API is a carbonic anhydrase inhibitor that works by decreasing the production of aqueous humor, a fluid in the eye that contributes to IOP. This reduction in fluid production helps to lower IOP and prevent damage to the optic nerve.

Q: What is the recommended dosage of brinzolamide API?

A: The recommended dosage of brinzolamide API will vary depending on the individual and their specific medical condition. It is important to follow the instructions of your healthcare provider and the prescription label carefully.

Q: What are the side effects of brinzolamide API?

A: Common side effects of brinzolamide API include blurred vision, burning or stinging of the eye, and a bitter taste in the mouth. If you experience serious side effects such as difficulty breathing or swelling of the face, lips, tongue or throat, seek medical attention immediately.


Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Anti Glaucoma Drugs' category

Back to top
Developed and Managed by Infocom Network Private Limited.